BIMI International Medical Inc. (BIMI) Financial Statements (2024 and earlier)

Company Profile

Business Address 725 5TH AVENUE, 15TH FLOOR, 15-01
NEW YORK, NY NEW YORK
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,9321,7302,3371,0475,0341,606
Cash and cash equivalents1,9321,7302,3371,0475,0341,606
Receivables6,3803,9153,2087,6626,2478,293
Inventory, net of allowances, customer advances and progress billings7,1838,4657,6541,2303,0282,170
Inventory7,1838,4657,6541,2303,0282,170
Prepaid expense7,0177,3176,6462165862
Deferred costs   (70,144)7947941,011
Intangible current assets    16  
Business combination, contingent consideration, asset1,498     
Other undisclosed current assets1,9853,55073,5346,4199,0168,913
Total current assets:25,99524,97823,23617,38424,17722,054
Noncurrent Assets
Operating lease, right-of-use asset2,8363,0292,9423,9774,3364,711
Property, plant and equipment1,6901,7921,7032,8843,1123,344
Long-term investments and receivables   1,800   
Long-term investments   1,800   
Intangible assets, net (including goodwill)2,5152,5782,0828,3928,3938,394
Goodwill2,0662,0662,0668,3768,3768,376
Intangible assets, net (excluding goodwill)44951216161718
Disposal group, including discontinued operation, noncurrent assets3,439     
Deferred income tax assets183193190186197208
Other undisclosed noncurrent assets  3,7053,761180  
Total noncurrent assets:10,66311,29612,47915,61916,03916,658
TOTAL ASSETS:36,65836,27435,71433,00340,21738,712
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,90712,32612,9939,9486,8978,015
Taxes payable390524693
Employee-related liabilities686
Accounts payable9,60510,09310,7864,2325,8506,629
Accrued liabilities2,3022,2322,2074,639524693
Debt1,2369939241,5662,0261,978
Due to related parties4,600476503532
Other liabilities5896146301,1221,069146
Other undisclosed current liabilities5,6588,6776,2155,78811,01410,023
Total current liabilities:19,39122,60925,36218,89921,50920,694
Noncurrent Liabilities
Long-term debt and lease obligation1261603153,8944,3124,624
Long-term debt, excluding current maturities126160315475472529
Liabilities, other than long-term debt2,6812,5872,575   
Accounts payable and accrued liabilities266     
Operating lease, liability2,4152,5872,5753,4193,8404,095
Other undisclosed noncurrent liabilities1,9482,2982,245(3,419)(3,840)(4,095)
Total noncurrent liabilities:4,7555,0465,1353,8944,3124,624
Total liabilities:24,14627,65430,49722,79325,82125,318
Equity
Equity, attributable to parent, including:10,8877,6054,0489,79814,15713,252
Common stock644382310
Additional paid in capital77,41777,42471,89965,76065,83460,566
Accumulated other comprehensive income (loss)(502)(1,060)252346341,052
Accumulated deficit(68,299)(71,027)(70,144)(56,234)(52,333) 
Other undisclosed equity, attributable to parent2,2642,2642,264  (48,376)
Equity, attributable to noncontrolling interest1,6261,0141,170412238142
Total equity:12,5128,6195,21710,21014,39613,394
TOTAL LIABILITIES AND EQUITY:36,65836,27435,71433,00340,21738,712

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues5,5583,198(5,432)7,3154,9275,020
Other operating income  884   2,740
Cost of revenue(2,674)(1,507)3,113(5,730)(3,702)(3,561)
Gross profit:2,8841,690(2,319)1,5851,2251,458
Operating expenses(1,585)(1,109)(5,092)(4,677)(3,504)(4,015)
Operating income (loss):1,299581(7,411)(3,092)(2,279)(2,557)
Nonoperating income (expense)(125)(1,441)(3,641)(623)(1,859)(161)
Investment income, nonoperating 00(3,261)000
Other nonoperating income (expense) (1,408)(576)(470)(1,751)(50)
Interest and debt expense(35)(35)146(97)(112)(108)
Income (loss) from continuing operations before equity method investments, income taxes:1,140(896)(10,905)(3,812)(4,250)(2,826)
Other undisclosed income (loss) from continuing operations before income taxes3535(146)97112108
Income (loss) from continuing operations before income taxes:1,174(861)(11,051)(3,715)(4,138)(2,718)
Income tax expense (benefit)   241(8)(23)
Income (loss) from continuing operations:1,174(861)(11,027)(3,714)(4,146)(2,740)
Loss before gain (loss) on sale of properties:(3,714)(4,146)(2,740)
Loss from discontinued operations(120)     
Other undisclosed net loss (0)(23)(690)   
Net income (loss):1,054(884)(11,717)(3,714)(4,146)(2,740)
Net income (loss) attributable to noncontrolling interest(0)(0)(79)111
Net income (loss) attributable to parent:1,054(884)(11,796)(3,713)(4,145)(2,739)
Other undisclosed net income (loss) available to common stockholders, basic   349  (1)
Net income (loss) available to common stockholders, basic:1,054(884)(11,447)(3,713)(4,145)(2,740)
Other undisclosed net income available to common stockholders, diluted  075   
Net income (loss) available to common stockholders, diluted:1,054(884)(11,372)(3,713)(4,145)(2,740)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):1,054(884)(11,717)(3,714)(4,146)(2,740)
Other comprehensive income (loss)106(2,844)    
Other undisclosed comprehensive income (loss)(860)1,759(210)(400)  
Comprehensive income (loss):301(1,968)(11,927)(4,114)(4,146)(2,740)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest5688973048851025
Other undisclosed comprehensive loss, net of tax, attributable to parent     (418)(550)
Comprehensive income (loss), net of tax, attributable to parent:869(1,071)(11,897)(3,626)(4,054)(3,266)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: